Also should see next-gen platform (payload/linker) presentation at same conference.
Takeda selected ADC will move more slowly, wouldn't be surprised if we don't see data until next year at AACR19.
All eyes on Wednesday 5PM...first clinical data for XMT-1536, sets the table for all science.
DS-8201 showing 60% ORR in Her2+ and 30% ORR in Her-low, those are the benchmarks for a competitive next-gen ADC in MBC.
Recent MRSN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 09:08:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 09:06:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:59:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:18:31 AM
- Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 11:00:02 AM
- Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 12:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 09:31:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:51:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:49:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:25:19 PM
- Mersana Therapeutics to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/22/2024 12:00:49 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/17/2024 12:26:06 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/10/2024 04:15:09 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 09:06:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 01:00:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:10:47 AM
- Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 10:59:33 AM
- Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:30:15 PM
- Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 12:00:42 PM
- Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/04/2024 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:08:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/28/2024 09:07:03 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/28/2024 09:05:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 01:49:00 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 02/28/2024 01:43:07 PM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM